- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05208957
Cardiovascular Outcomes and Mortality in Vascular Surgical Patients
July 15, 2024 updated by: Christella Alphonsus, University of Cape Town
Cardiovascular Outcomes and Mortality in Vascular Surgical Patients. A Registry-based Study of in Hospital Mortality and Postoperative Complications in Elective Vascular Surgery at Groote Schuur Hospital
This is a registry-based study of elective vascular surgical patients undergoing intermediate or high-risk vascular surgical interventions at Groote Schuur hospital, a tertiary academic center, over a 12 month period.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
175
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Western Cape
-
Cape Town, Western Cape, South Africa, 7708
- Groote Schuur Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population comprises all patients, 18 years and older, undergoing any elective moderate- to high-risk vascular surgical intervention at Groote Schuur Hospital.
Surgical risk as defined by ESC/ESA 2014 guidelines.
Description
Inclusion Criteria:
-
All patients undergoing vascular surgery:
- 18 years and older
- Elective procedures
- Moderate- to high-risk surgical interventions
Exclusion Criteria:
- Emergency vascular procedures
- Low risk vascular surgery, i.e. venous stripping
- All non-vascular surgical interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Determine in-hospital mortality in elective vascular surgical patients
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Determine incidence of MACE in elective vascular surgical patients.
Time Frame: 12 months
|
12 months
|
|
Describe the risk factors associated with MACE in elective vascular surgical patients
Time Frame: 12 months
|
12 months
|
|
Determine incidence of post-operative complications in elective vascular surgical patients
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christella Alphonsus, MBChB, University of Cape Town
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 17, 2022
Primary Completion (Actual)
November 30, 2023
Study Completion (Actual)
November 30, 2023
Study Registration Dates
First Submitted
January 12, 2022
First Submitted That Met QC Criteria
January 25, 2022
First Posted (Actual)
January 26, 2022
Study Record Updates
Last Update Posted (Actual)
July 16, 2024
Last Update Submitted That Met QC Criteria
July 15, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- HREC760/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data will be shared by PI
IPD Sharing Time Frame
Not limited
IPD Sharing Access Criteria
Contact PI
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perioperative Complication
-
Medical University of GdanskUniversity Clinical Centre, Gdansk; EIT HealthRecruitingCardiac Complication | Perioperative ComplicationPoland
-
Uppsala University HospitalCompletedPerioperative ComplicationSweden
-
Assiut UniversityNot yet recruitingPerioperative Complication
-
Peking Union Medical College HospitalRecruitingPerioperative ComplicationChina
-
University of FlorenceRecruiting
-
Istanbul UniversityCompletedPerioperative Complication
-
Karolinska InstitutetRecruitingGeneral Surgery | Perioperative Medicine | Physical Inactivity | Perioperative ComplicationSweden
-
Emory UniversityvmasterRecruiting
-
Samsun UniversityCompleted
-
University Hospital, GenevaCompletedPerioperative ComplicationSwitzerland
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted